v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (63,746) $ (92,698)
Adjustments to reconcile net loss to net cash provided by operating activities:    
(Gain) loss on sale or write down of assets, net (13,443) 24,472
Depreciation and amortization 175,245 186,418
Amortization of discount on mortgage notes payable 8,325 18,241
Amortization of share and unit-based plans 12,642 8,505
Straight-line rent and amortization of above and below market leases (3,848) (2,378)
Provision for doubtful accounts 3,133 2,356
Income tax benefit (2,146) (1,010)
Equity in loss of unconsolidated joint ventures 15,103 1,274
Changes in assets and liabilities, net of dispositions:    
Tenant and other receivables 17,351 21,677
Other assets 13,436 10,799
Due from affiliates (659) (1,641)
Accounts payable and accrued expenses 11,754 14,439
Other accrued liabilities (28,899) (31,444)
Net cash provided by operating activities 144,248 159,010
Cash flows from investing activities:    
Acquisitions of property (270,111) (266,926)
Development, redevelopment, expansion and renovation of properties (79,257) (59,956)
Property improvements (53,734) (17,544)
Deferred leasing costs (3,790) (2,191)
Distributions from unconsolidated joint ventures 42,606 51,839
Contributions to unconsolidated joint ventures (44,426) (110,323)
Proceeds from sale of assets 15,946 90,441
Net cash used in investing activities (392,766) (314,660)
Cash flows from financing activities:    
Proceeds from mortgages, bank and other notes payable 250,000 440,000
Payments on mortgages, bank and other notes payable (479,945) (134,666)
Deferred financing costs (14,838) (1,729)
Payments on finance leases 0 (4,408)
Proceeds (costs) from stock offerings, net 531,839 (639)
Employee stock purchases 1,104 1,251
Redemption of noncontrolling interests (830) 0
Dividends and distributions (100,829) (96,165)
Net cash provided by financing activities 186,501 203,644
Net (decrease) increase in cash, cash equivalents and restricted cash (62,017) 47,994
Cash, cash equivalents and restricted cash, beginning of period 372,963 177,479
Cash, cash equivalents and restricted cash, end of period 310,946 225,473
Supplemental cash flow information:    
Cash payments for interest, net of amounts capitalized 109,119 101,276
Non-cash investing and financing transactions:    
Accrued development costs included in accounts payable and accrued expenses and other accrued liabilities 63,055 43,059
Conversion of Operating Partnership Units to common stock $ 5,383 $ 118